Phenotypic variation during cloning procedures: Analysis of the growth behavior of clonal cell lines

Biotechnology and Bioengineering

Volumn 94, Issue 3, 2006, Pages 530-537

  Barnes, Louise M ^a   Moy, Nicola ^b   Dickson, Alan J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cloned cell line; Limiting dilution cloning (LDC); Mammalian cell growth; NS0 myeloma; p27 protein expression; Phenotypic drift

Indexed keywords

CELLS; FEATURE EXTRACTION; GENES; GROWTH KINETICS; PROTEINS;

CLONED CELL LINE; LIMITING DILUTION CLONING (LDC); MAMMALIAN CELL GROWTH; NS0 MYELOMA; P27 PROTEIN EXPRESSION; PHENOTYPIC DRIFT;

CLONING;

PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CLONING; CELL CYCLE REGULATION; CELL GROWTH; CELL LINE; CONTROLLED STUDY; GENETIC TRANSFECTION; MOLECULAR CLONING; MOUSE; NONHUMAN; PHENOTYPIC VARIATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MICE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECOMBINANT PROTEINS;

MAMMALIA;

EID: 33745221421     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.20856     Document Type: Article

References (28)

1. Antoniou M, Harland L, Mustoe T, Williams S, Holdstock J, Yague E, Mulcahy T, Griffiths M, Edwards S, Ioannou PA, Mountain A, Crombie R. 2003. Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics 82:269-279.
2. Barnes LM, Bentley CM, Dickson AJ. 2000. Advances in animal cell recombinant protein production: GS-NS0 expression system. Cytotechnology 32:109-123.
3. Barnes LM, Bentley CM, Dickson AJ. 2001. Characterization of the stability of recombinant protein production in the GS-NS0 expression system. Biotechnol Bioeng 73:261-270.
4. Barnes LM, Bentley CM, Dickson AJ. 2003a. Stability of protein production from recombinant mammalian cells. Biotechnol Bioeng 81:631-639.
5. Barnes LM, Bentley CM, Dickson AJ. 2003b. Stability of recombinant protein production in the GS-NS0 expression system is unaffected by cryopreservation. Biotechnol Prog 19:233-237.
6. Barnes LM, Bentley CM, Dickson AJ. 2004. Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells. Biotechnol Bioeng 85:115-121.
7. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-due binding. Anal Biochem 72:248-254.
8. Carvalhal AV, Marcelino I, Carrondo MJT. 2003. Metabolic changes during cell growth inhibition by p27 overexpression. Appl Microbiol Biotechnol 63:164-173.
9. Clarke J, Porter AJ, Thorpe R, Davis JM. 2002. Cloning. In: Davis JM, editor. Basic Cell Culture: A Practical Approach. 2nd ed. Oxford: Oxford University Press. pp 275-294.
10. Coller HA, Coller BS. 1986. Poisson statistical analysis of repetitive subcloning by the limiting dilution technique as a way of assessing hybridoma monoclonality. Methods Enzymol 121:412-417.
11. Donjerkovic D, Scott DW. 2000. Regulation of the G1 phase of the mammalian cell cycle. Cell Res 10:1-16.
12. Flintoff WF, Livingston E, Duff C, Worton RG. 1984. Moderate-level gene amplification in methotrexate-resistant Chinese hamster ovary cells is accompanied by chromosomal translations at or near the site of amplified DHFR gene. Mol Cell Biol 4:69-76.
13. Fussenegger M, Mazur X, Bailey JE. 1997. A novel cytostatic process enhances the productivity of Chinese hamster ovary cells. Biotechnol Bioeng 55:927-939.
14. Hayter PM, Kirkby NF, Spier RE. 1992. Relationship between hybridoma growth and monoclonal antibody production. Enzyme Microb Technol 14:454-461.
15. KIP1 accumulation during the cell cycle. Science 271:1861-1864.
16. Hulleman E, Boonstra J. 2001. Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell Mol Life Sci 58:80-93.
17. ICH guideline. 1996. Quality of Biotechnological Products: Analysis of the expression construct in cells used for production of r-DNA derived protein products. ICH harmonised tripartite guideline. website: http://www.fda.gov/cder/ guidance/ichq5b.pdf, Q5b.
18. Kim NS, Kim SJ, Lee GM. 1998. Clonal variability within dihydrofolate reductase-mediated gene amplified Chinese hamster ovary cells: stability in the absence of selective pressure. Biotechnol Bioeng 60:679-688.
19. Mazur X, Fussenegger M, Renner WA. 1998. Higher productivity of growth-arrested Chinese hamster ovary cells expressing the cyclin-dependent kinase inhibitor p27. Biotechnol Prog 14:705-713.
20. Morisaki H, Fujimoto A, Ando A, Nagata Y, Ikeda K, Nakanishi M. 1997. Cell cycle dependent phosphorylation of p27 cyclin dependent kinase (CDK) inhibitor by cyclin E/CDK2. Biophys Res Comm 240:386-390.
21. 1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome. Mol Cell Biol 19:1190-1201.
22. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Sal GD, Chau V, Yew PR, Draetta GF, Rolfe M. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
23. Santarén JF, Bravo R. 1986. A basic cytoplasmic protein (p27) induced by serum in growth-arrested 3T3 cells but constitutively expressed in primary fibroblasts. EMBO J 5:877-882.
24. Toyoshima H, Hunter T. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
25. Kip1. EMBO J 16:5334-5344.
26. Werner RG, Noé W, Kopp K, Schlüter M. 1998. Appropriate mammalian expression systems for biopharmaceuticals. Arzneim-Forsch/Drug Res 48:870-880.
27. Wurm F. 2004. Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnol 22:1393-1398.
28. Yoshikawa T, Nakanishi F, Ogura Y, Oi D, Omasa T, Katakura Y, Kishimoto M, Suga K. 2000. Amplified gene location in chromosomal DNA affected recombinant protein production and stability of amplified genes. Biotechnol Prog 16:710-715.